Aysha Arshad, MD
Clinical Cardiac Electrophysiology · Manassas, VANPI 1710964960
Payments from drug & device makers
Across 463 payments — averaging $179.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$31K
- Cvrx, Inc.$29K
- Medtronic$13K
- Boston Scientific$4K
- E.r. Squibb & Sons, L.L.C.$719
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$531
- plus $5K from 34 others
Across 4 payments — averaging $3412.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$14K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 137 | $30,781 |
| Cvrx, Inc. | 29 | $28,809 |
| Medtronic(2 entities) | 119 | $12,928 |
| Boston Scientific | 27 | $3,970 |
| E.r. Squibb & Sons, L.L.C. | 24 | $719 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $531 |
| Novo Nordisk | 6 | $512 |
| Philips North America LLC | 8 | $429 |
| Pfizer | 16 | $411 |
| Johnson & Johnson | 6 | $386 |
| Amgen | 10 | $327 |
| AstraZeneca | 8 | $323 |
| Novartis | 8 | $292 |
| Scpharmaceuticals Inc. | 4 | $271 |
| Kestra Medical Technology Services, Inc. | 5 | $255 |
| Bridgebio Pharma, Inc. | 2 | $177 |
| Atricure, Inc. | 2 | $162 |
| Sanofi-aventis U.S. LLC | 3 | $158 |
| Merck | 8 | $158 |
| Biosense Webster, Inc. | 5 | $145 |
| ZOLL Respicardia, Inc. | 1 | $136 |
| Lilly USA, LLC | 1 | $125 |
| Ionis Pharmaceuticals, Inc. | 1 | $122 |
| Bayer | 1 | $119 |
| Cardiva Medical, Inc. | 1 | $119 |
| Esperion Therapeutics, Inc. | 2 | $116 |
| Boehringer Ingelheim | 1 | $102 |
| Baxter Healthcare | 2 | $101 |
| Actelion Pharmaceuticals US, Inc. | 1 | $66 |
| Recor Medical Inc | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Cardiovascular Systems Inc. | 1 | $25 |
| Qorumpartners | 1 | $20 |
| Abiomed | 1 | $19 |
| Bardy Diagnostics, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| GSK | 1 | $16 |
| Chiesi USA, Inc. | 1 | $15 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $13 |
| Altathera Pharmaceuticals LLC | 1 | $11 |
How this compares
$82,951 in reported general payments places this provider in the 65th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical cardiac electrophysiology in Manassas
- Kenneth EllenbogenRichmond$1.4M
- Brett AtwaterFairfax$1.2M
- Pamela MasonCharlottesville$894K
- Erich KiehlNewport News$862K
- James MangrumCharlottesville$717K
- Haroon RashidFalls Church$602K
- Sarfraz DurraniFairfax$564K
- Kenneth BilchickCharlottesville$554K
- Philip GentleskNorfolk$530K
- Jayanthi KoneruRichmond$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.